BI 765250

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BI 765250, covering 2025-01-22 to 2025-03-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis [Phase 1]

See pricing